Medications

Am I a Candidate for GLP-1 Medication? Understanding Eligibility Criteria

  • January 25, 2026
  • 0

Not everyone qualifies for GLP-1 medications, and medical eligibility doesn’t always mean insurance coverage. This guide explains official criteria and how eligibility is determined.

Am I a Candidate for GLP-1 Medication? Understanding Eligibility Criteria

Who qualifies for GLP-1 weight loss medications?

You may be a candidate for GLP-1 medications like Ozempic, Mounjaro, or Wegovy if you have a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition like high blood pressure, type 2 diabetes, high cholesterol, or sleep apnea. However, eligibility also depends on your specific health history, potential contraindications, and whether your insurance will cover the medication.

Basic qualification criteria:

  • BMI ≥30: Qualifies for weight management regardless of other conditions
  • BMI 27-29.9 with comorbidities: High blood pressure, type 2 diabetes, cardiovascular disease, sleep apnea, PCOS, or other weight-related conditions
  • Type 2 diabetes: May qualify at lower BMI thresholds if current medications aren’t controlling blood sugar adequately
  • Age 18+ (or 12+ for some medications): Most GLP-1s are approved for adults, some for adolescents with obesity

Who should NOT take GLP-1s:

Personal or family history of medullary thyroid cancer, pregnancy or planning pregnancy, type 1 diabetes, severe gastroparesis, or Multiple Endocrine Neoplasia syndrome type 2.

This guide walks you through medical criteria, insurance versus medical eligibility differences, contraindications, and how to get properly evaluated by a healthcare provider.

IMPORTANT DISCLAIMER: This article provides general information about GLP-1 medication eligibility criteria for educational purposes only. It is not medical advice and should not be used as a substitute for professional medical consultation. Only a qualified healthcare provider can evaluate your individual medical history, current health status, and specific circumstances to determine whether GLP-1 medications are appropriate and safe for you. The information provided here does not constitute a diagnosis or treatment recommendation. Always consult with your doctor or healthcare provider before starting, stopping, or changing any medication.

Official Medical Criteria for GLP-1s

Woman looking at her BMI chart

The FDA has approved different GLP-1 medications for different uses, but the weight loss indications follow similar criteria.

BMI-based eligibility:

You may qualify for GLP-1 medications if you meet one of these criteria:

  • BMI ≥30: Anyone with a body mass index of 30 or higher qualifies for weight management, regardless of other health conditions. This is classified as obesity.
  • BMI ≥27 with weight-related condition: If your BMI is 27-29.9 (classified as overweight), you need at least one weight-related health condition to qualify. This is sometimes called comorbidity.

Weight-related conditions that may qualify you:

  • Type 2 diabetes
  • High blood pressure (hypertension)
  • High cholesterol or high triglycerides (dyslipidemia)
  • Obstructive sleep apnea
  • Cardiovascular disease
  • Fatty liver disease (non-alcoholic fatty liver disease/NAFLD)
  • Polycystic ovary syndrome (PCOS)
  • Osteoarthritis made worse by excess weight

Type 2 diabetes considerations:

Ozempic has been FDA-approved specifically for type 2 diabetes management at certain doses. If you have type 2 diabetes, you may qualify even if your BMI is lower than the weight loss thresholds, though this depends on your current diabetes management and A1C levels.

Doctors typically consider GLP-1s for diabetes when:

  • Your A1C is above target (generally above 7% for most adults)
  • Current medications aren’t adequately controlling blood sugar
  • You’re trying to avoid or delay insulin
  • You have obesity or overweight along with diabetes

Cardiovascular disease prevention:

In 2024, Wegovy received FDA approval for reducing cardiovascular risk in adults with established cardiovascular disease and either obesity or overweight. This means if you have a history of heart attack, stroke, or peripheral artery disease along with a BMI ≥27, you may qualify even without the other conditions listed above.

Age considerations:

Most GLP-1 medications are approved for adults 18 and older. Some (like Saxenda) are approved for adolescents age 12+ with obesity. Wegovy is approved for children 12+ with obesity. Specific age requirements vary by medication.

Who Should NOT Take GLP-1s

Images of people who are eligible for GLP-1s

Certain medical conditions and situations make GLP-1 medications unsafe or inappropriate. These are absolute or strong relative contraindications.

Medical contraindications:

  • Personal or family history of medullary thyroid cancer (MTC): GLP-1s carry a black box warning about thyroid C-cell tumors. If you or a close family member has had MTC, these medications are contraindicated.
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2): This genetic condition that increases risk of certain tumors is an absolute contraindication.
  • History of pancreatitis: Previous pancreatitis is a relative contraindication. Some doctors won’t prescribe GLP-1s if you’ve had pancreatitis; others will with careful monitoring.
  • Pregnancy or planning pregnancy: GLP-1 medications are not approved for use during pregnancy. You should stop them at least 2 months before trying to conceive.
  • Breastfeeding: Not recommended while breastfeeding due to unknown effects on infants.
  • Type 1 diabetes: GLP-1s are not approved for type 1 diabetes and are not a substitute for insulin in type 1.
  • Severe gastroparesis: Since GLP-1s slow stomach emptying, they can worsen existing gastroparesis.
  • History of severe GI disease: Conditions like inflammatory bowel disease may be worsened by GLP-1s in some cases.

Medications that may interact:

  • Insulin: Can be used together but requires dose adjustments to prevent hypoglycemia
  • Sulfonylureas: Diabetes medications that may cause low blood sugar when combined with GLP-1s
  • Oral medications with narrow therapeutic windows: GLP-1s slow stomach emptying, which can affect absorption of some oral medications
  • Warfarin: May need INR monitoring adjustment

Other considerations:

  • Active gallbladder disease: GLP-1s may increase gallstone risk
  • Severe kidney disease: May require dose adjustments or different medication choices
  • History of eating disorders: Requires careful consideration and mental health support
  • History of severe depression or suicidal thoughts: Some concern about mood effects, though rare

Insurance vs Medical Eligibility for GLP-1s

Insurance office for GLP-1s

Meeting medical criteria doesn’t automatically mean your insurance will cover GLP-1 medications. Insurance eligibility is often more restrictive than medical eligibility.

Why these differ:

Medical eligibility is based on FDA approvals and clinical guidelines about who can safely and effectively use the medication. Insurance eligibility is based on coverage policies designed to control costs. Insurance companies often add requirements beyond what the FDA or medical guidelines specify.

Typical insurance requirements:

Most insurance plans that cover GLP-1s for weight loss require:

  • Documentation of BMI ≥30 or BMI ≥27 with comorbidities (same as medical criteria)
  • History of failed weight loss attempts through diet and exercise
  • No contraindications
  • Prior authorization from your doctor
  • Sometimes: participation in a weight management program
  • Sometimes: documented weight loss attempts with specific other medications first

Many insurance plans still don’t cover GLP-1 medications for weight loss at all, only for type 2 diabetes. Even when covered, many plans apply high cost-sharing or place them in specialty tiers requiring significant copays.

Prior authorization basics:

Prior authorization means your doctor must submit documentation to your insurance company proving you meet their specific criteria before they’ll approve coverage. This process typically requires:

  • Letter of medical necessity from your doctor
  • Documentation of your BMI and any weight-related conditions
  • Records showing previous weight loss attempts
  • Sometimes photos or additional documentation
  • Current medication list

The prior authorization process can take 1-4 weeks. Denials are common on first submission and often require appeals.

Off-label considerations:

If your BMI is under 27, or you don’t have qualifying conditions, any use would be “off-label” (not FDA-approved for your situation). Some doctors will prescribe off-label if they believe the benefits outweigh risks. However, insurance will almost never cover off-label use for weight loss, meaning you’d pay out-of-pocket costs of $900-$1,400/month for brand-name or $200-$400/month for compounded versions.

How to Get Evaluated for GLP-1 Medications

Getting evaluated for GLP-1 medications involves either a traditional in-person doctor visit or a telehealth consultation.

Traditional doctor visit process:

Start with your primary care physician or endocrinologist. They’ll:

  1. Review your medical history and current medications
  2. Calculate your BMI and discuss weight-related health conditions
  3. Discuss your weight loss goals and previous attempts
  4. Review contraindications and potential risks specific to you
  5. Order any necessary lab work (metabolic panel, thyroid function, A1C if diabetic)
  6. Provide education about how the medication works and what to expect
  7. Write a prescription if appropriate
  8. Submit prior authorization to your insurance if needed

The benefit of this approach is comprehensive medical evaluation by a provider who knows your full medical history. The downside is it requires in-person visits, potentially multiple appointments, and insurance navigation.

Telehealth evaluation differences:

Many companies now offer GLP-1 medications through telehealth platforms (Ro, Hers, Calibrate, Found, and others). The process typically involves:

  1. Online questionnaire about medical history, current medications, and weight
  2. Virtual consultation with a healthcare provider (video or asynchronous)
  3. Provider determines eligibility and writes prescription
  4. Medication shipped directly to you (usually compounded, not brand-name)
  5. Ongoing virtual monitoring and support

Telehealth is faster and more convenient, often getting you medication within days rather than weeks. However, the evaluation may be less thorough than in-person care, you’re typically getting compounded rather than FDA-approved medications, and insurance usually doesn’t cover telehealth GLP-1 services (you pay out-of-pocket monthly fees).

What documentation helps:

Bring or have available:

  • Recent weight history (if tracked)
  • Previous lab results, especially A1C if diabetic
  • List of all current medications and supplements
  • Documentation of weight-related health conditions
  • Records of previous weight loss attempts, if available
  • Family health history, particularly thyroid cancer

Questions to ask your provider:

  • Based on my medical history, am I a good candidate for GLP-1 medications?
  • Are there any specific concerns or contraindications for me?
  • Which GLP-1 medication do you recommend and why?
  • What side effects should I expect and how do we manage them?
  • How will we monitor my progress and health while on this medication?
  • What’s the plan if I don’t tolerate the medication well?
  • Does my insurance cover this, and what’s the prior authorization process?
  • What are my options if insurance doesn’t cover it?

Quick Decision Flowchart

Chart showing eligibility criteria for GLP-1s

You may qualify if:

  • Your BMI is 30 or higher
  • Your BMI is 27-29.9 AND you have high blood pressure, type 2 diabetes, high cholesterol, sleep apnea, or another weight-related condition
  • You have type 2 diabetes that’s not well controlled with current medications
  • You have cardiovascular disease with BMI ≥27
  • You’re 18+ years old (or 12+ for some medications)
  • You don’t have a personal or family history of medullary thyroid cancer
  • You’re not pregnant, planning pregnancy, or breastfeeding

You likely don’t qualify if:

  • Your BMI is under 27
  • Your BMI is 27-29.9 and you have no weight-related health conditions
  • You have a personal or family history of medullary thyroid cancer or MEN 2
  • You’re currently pregnant or breastfeeding
  • You have type 1 diabetes (not approved for this use)
  • You have active severe gastroparesis
  • You’ve had severe pancreatitis

Still unsure? Talk to a healthcare provider. Individual circumstances matter, and what works for someone else might not be appropriate for you.

Next Steps

If you think you might qualify for GLP-1 medications based on the criteria above, the next step is getting properly evaluated by a qualified healthcare provider.

Schedule an appointment with your primary care doctor, endocrinologist, or a telehealth provider that specializes in weight management. Come prepared with your medical history, questions, and realistic expectations about the process.

Remember that meeting eligibility criteria doesn’t guarantee insurance coverage, and lack of insurance coverage doesn’t mean you can’t access these medications (though cost becomes a significant consideration).

Most importantly, GLP-1 medications are tools, not magic solutions. They work best as part of a comprehensive approach that includes nutrition, movement, and lifestyle changes. The right healthcare provider will help you determine not just whether you qualify, but whether this medication makes sense for your individual health goals and circumstances.

Only a qualified medical professional can make that determination for you.

Related Resources About GLP-1s